Invention Grant
- Patent Title: Combination therapy with apilimod and glutamatergic agents
-
Application No.: US17862471Application Date: 2022-07-12
-
Publication No.: US11957688B2Publication Date: 2024-04-16
- Inventor: Henri Lichenstein , Sean Landrette , Peter Ronald Young , Jonathan M. Rothberg
- Applicant: AI Therapeutics, Inc.
- Applicant Address: US CT Guilford
- Assignee: OrphAl Therapeutics Inc.
- Current Assignee: OrphAl Therapeutics Inc.
- Current Assignee Address: US CT Guilford
- Agency: DLA Piper LLP (US)
- Main IPC: A61K31/5375
- IPC: A61K31/5375 ; A61K9/00 ; A61K31/4152 ; A61K31/428 ; A61K31/496 ; A61K31/5377 ; A61K31/66 ; A61K31/675 ; A61K45/06 ; A61P25/00 ; A61P25/08 ; A61P25/28
Abstract:
Provided are compositions and methods related to the use of apilimod in combination with glutamatergic agents for treating neurological diseases and disorders, and for the treatment of cancer.
Public/Granted literature
- US20230069069A1 COMBINATION THERAPY WITH APILIMOD AND GLUTAMATERGIC AGENTS Public/Granted day:2023-03-02
Information query
